Senores Pharma has named Anar Modi as the Chief Heart Officer (CHO) of its group.
The announcement was made through a LinkedIn post, where the company stated, “We’re excited to announce that Ms. Anar Modi will now be leading our group as the Chief Heart Officer (CHO)! She has been a driving force behind our collaborative, growth-oriented, and people-first culture. Her unwavering commitment to employee well-being and organizational development has set a strong foundation for an even brighter future. In this new role CHO, Ms. Modi will continue to champion a workplace where every team member feels supported, heard, and empowered.”
“She will remain deeply involved in the well-being of our people and will be available for meaningful conversations by prior appointment. We’re confident that under her compassionate leadership, our focus on building a thriving, people centric environment will only grow stronger,” Senores further stated.
Before joining Senores, Anar Modi served as Director – Business Development (US & UK) at Espee Group. She is an MBA in Marketing and Entrepreneurship from the Institute of Management, Nirma University.
Senores Pharmaceuticals Limited is a global, research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the US, Canada, and other regulated and emerging markets across various therapeutic areas and dosage forms. The companies’ current portfolio includes 61 ANDA and 22 CMO/CDMO commercial products that are permitted for distribution in the USA. Senores is also engaged in the development and manufacturing of complex generics certified by global food and drugs authorities and delivers generic drugs for emerging markets, catering to more than 40 countries.
The company currently has approval from regulatory bodies of more than 10 countries for its manufacturing facility in Chhatral for emerging markets with over 280 product registrations and 630 product applications. Senores also manufactures critical care injectables and Active Pharmaceutical Ingredients (“API”). Senores has 2 manufacturing facilities for formulations – one in Atlanta, US which is USFDA approved and DEA, TAA & BAA compliant for controlled substances and government supplies & other is in Chhatral, Ahmedabad, India approved by WHO-GMP to cater to emerging markets. The company also has 2 manufacturing facilities for API in India, both located around Ahmedabad, with one in Chhatral and the other in Naroda.
Source: Medical Dialogues
